Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 441 clinical trials
Impact of Pomegranate Seed Oil on Postprandial Cardiovascular Disease Risk Markers

However, research comparing the impact of these fatty acids on postprandial vascular function, particularly in postmenopausal women, remains limited. A cross-over, single-blind, randomised acute postprandial study will be conducted in 15 healthy postmenopausal women. Participants will be assigned to consume the test meals either a placebo (50 g of mixed …

Accepts healthy volunteers
  • 0 views
  • 22 Sep, 2023
  • 1 location
Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide

Immunotherapy may also contribute to the efficacy of systemic treatment by maintaining initial responses to chemotherapy. A double-blind, placebo-controlled phase 3 trial indicates that the addition of atezolizumab to standard chemotherapy significantly improves overall survival and progression-free survival compared with chemotherapy alone in treatment-nave patients with ED-SCLC who are in …

cancer
immunodeficiency
angina pectoris
carboplatin
non-small cell lung cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
COVID-19 First In Human Study to Evaluate Safety Tolerability and Pharmacokinetics of EIDD-2801 in Healthy Volunteers

This is a First In Human study designed to assess the safety, tolerability and pharmacokinetics of EIDD-2801 in healthy human volunteers.

screening procedures
covid-19
body mass index
  • 0 views
  • 05 Aug, 2020
To Evaluate the Safety Tolerability and Pharmacokinetics Profiles of TG-1000 in Healthy Volunteers and the Food Effect on Pharmacokinetics of Single Oral Dose of TG-1000 in Healthy Volunteers.

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics profiles of TG-1000 in healthy volunteers, and to evaluate the food effect on pharmacokinetics of single oral dose of TG-1000 in healthy volunteers.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients

This exploratory study is designed to compare safety and efficacy between a Tegoprazan dose-specific standard triple therapy and Lansoprazole standard triple therapy in H. pylori positive patients.

  • 0 views
  • 06 Jul, 2023
  • 1 location
Efficacy and Safety of Angelica Gigas Nakai and Allium Cepa L.Extract Mixtures on the Improvement of Blood Flow

This study was conducted to investigate the effects of daily supplementation of Angelica Gigas Nakai and Allium Cepa L.Extract Mixtures on the Improvement of Blood Flow.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Safety and Immunogenicity Study of GX-19 a COVID-19 Preventive DNA Vaccine in Healthy Adults

The objective of our study is to evaluate safety, tolerability, and immunogenicity of COVID-19 preventive DNA vaccine in healthy volunteers.

covid-19
dna vaccine
body mass index
  • 0 views
  • 16 Feb, 2024
  • 1 location
Clinical Trial Scheme of Huangqi Guizhi Wuwu Decoction

To evaluate the efficacy and safety of Huangqi Guizhi Wuwu decoction in preventing oxaliplatin induced peripheral neurotoxicity.

capecitabine
blood transfusion
oxaliplatin
neutrophil count
adjuvant chemotherapy
  • 0 views
  • 16 Feb, 2024
  • 2 locations
Combining Cereals With Pulses - Reduced Gastrointestinal Symptoms?

The aim of the study is to compare self-reported gastrointestinal symptoms and intestinal fermentation rates of the study products as measured by breath hydrogen and methane in adult population with self-reported mild abdominal sensitivity to pulses. The study products are a pulse products with two different cereals.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)

This Phase III study will be conducted to evaluate the efficacy and safety of YH25448 as first-line treatment in locally advanced or metastatic Non-small Cell Lung Cancer (NSCLC) patients with EGFR mutations

EGFR
stage iv non-small cell lung cancer
small cell lung cancer
measurable disease
lazertinib
  • 0 views
  • 16 Feb, 2024
  • 29 locations